Colorectal and Peritoneal Oncology Annual Service Report 2021 - 2022

Service Report 2022 Colorectal and Peritoneal Oncology Centre – The Christie NHS Foundation Trust

surveillance pathway and outcomes from Laparoscopic CRS/HIPEC for perforated LAMNs. We are a major contributor to the PSOGI international collaborative laparoscopic CRS/HIPEC registry which has published its results.

5.4 Conferences and Meetings

ACPGBI Annual Conference 2022

•

o “Appendiceal adenocarcinoma treated at a national peritoneal tumour centre” (Verbal and Poster) (M Strach, J Barriuso, B Chakrabarty, S O’Dwyer, O Aziz) o “Investigating the role of the extracellular matrix in the peritoneal dissemination of pseudomyxoma pe ritonei” (Poster) (M McAllister, O Aziz, D Thornton, S O’Dwyer, & P Caswell) o “Proteomics profile and quantitation of pharmacokinetics (PK) and pharmacodynamics (PD) targets in liver, small intestine, colon, and peritoneal cancer” (Poster) (A -M Vasilogianni, O Aziz, S O'Dwyer, J Barriuso, C Demonacos, SA Peters, A Rostami-Hodjegan, J Barber) o “Patterns and Timing of recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis” (Poster) (Sarah)

• Karolinska Institute Rectal Cancer Forum 2022

o “Developing an extension to the CR29 for rectal patients having organ preserving treatment” (Poster) (A Gilbert, R Fish)

• European Association for Clinical Pharmacology and Therapeutics 2022

o “Quantitative Proteomics of Hepatic Drug -Metabolizing Enzymes and Transporters in Patients with Colorectal Cancer Liver Metastasis” (Oral) (A‐M Vasilogianni, Z M Al‐Majdoub, B Achour, S A Peters, J Barber, A Rostami‐Hodjegan)

• The Centre for Applied Pharmacokinetic research (CAPKR) Annual Meeting 2022

o “The Human Appendix Is Not There To Be Ignored” (Oral) (A‐M Vasilogianni)

ACPGBI Annual Conference 2021

•

o “IntraPeritoneal Disease -Free Survival after complete cytoreductive surgery and HIPEC for colorectal peritoneal metastases”.(Published) (H Clouston, J Convill, O Aziz, J Wild, C Selvasekar, M S Wilson, S O’Dwyer, A Renehan) o “Complications following complete cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a UK national treatment centre experience compared with recent trial outcomes”. (Published) (H Clouston, J Convill, O Aziz, M Saunders, J Barriuso, M S Wilson, Sarah O’Dwyer, A Renehan) o “Average cumulative relative dose (ACRD) of adjuvant chemotherapy is more important than average relative dose intensity (ARDI) for colorectal cancer survival, with implications for treating obese patients: the OCTOPUS con sortium”. (Poster) (C Slawinski, L Malcomson, H Guo, J Barriuso, A Harkin, T Iveson, R Glynne-Jones, C van de Velde, A Renehan)

19